TITLE

Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

AUTHOR(S)
Hocking, William G.; Ping Hu; Oken, Martin M.; Winslow, Stephen D.; Kvale, Paul A.; Prorok, Philip C.; Ragard, Lawrence R.; Commins, John; Lynch, David A.; Andriole, Gerald L.; Buys, Saundra S.; Fouad, Mona N.; Fuhrman, Carl R.; Isaacs, Claudine; Yokochi, Lance A.; Riley, Thomas L.; Pinsky, Paul F.; Gohagan, John K.; Berg, Christine D.
PUB. DATE
May 2010
SOURCE
JNCI: Journal of the National Cancer Institute;5/19/2010, Vol. 102 Issue 10, p722
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The 5-year overall survival rate of lung cancer patients is approximately 15%. Most patients are diagnosed with advanced-stage disease and have shorter survival rates than patients with early-stage disease. Although screening for lung cancer has the potential to increase early diagnosis, it has not been shown to reduce lung cancer mortality rates. In 1993, the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was initiated specifically to determine whether screening would reduce mortality rates from PLCO cancers.
ACCESSION #
50641034

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics